222 related articles for article (PubMed ID: 29929196)
1. Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling.
Xie L; He S; Kong N; Zhu Y; Tang Y; Li J; Liu Z; Liu J; Gong J
Cell Physiol Biochem; 2018; 47(4):1389-1398. PubMed ID: 29929196
[TBL] [Abstract][Full Text] [Related]
2. CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling.
Cao Z; Ren D; Ha T; Liu L; Wang X; Kalbfleisch J; Gao X; Kao R; Williams D; Li C
Biochim Biophys Acta; 2013 Jan; 1832(1):96-104. PubMed ID: 22917564
[TBL] [Abstract][Full Text] [Related]
3. The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling.
Lu C; Ha T; Wang X; Liu L; Zhang X; Kimbrough EO; Sha Z; Guan M; Schweitzer J; Kalbfleisch J; Williams D; Li C
J Am Heart Assoc; 2014 Apr; 3(2):e000629. PubMed ID: 24721797
[TBL] [Abstract][Full Text] [Related]
4. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
5. Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model.
Kim SC; Wu S; Fang X; Neumann J; Eichhorn L; Schleifer G; Boehm O; Meyer R; Frede S; Hoeft A; Baumgarten G; Knuefermann P
Life Sci; 2014 Dec; 119(1-2):1-8. PubMed ID: 25445440
[TBL] [Abstract][Full Text] [Related]
6. Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway.
Xie L; Liu S; Cheng J; Wang L; Liu J; Gong J
Regul Toxicol Pharmacol; 2017 Oct; 89():148-154. PubMed ID: 28757323
[TBL] [Abstract][Full Text] [Related]
7. The toll-like receptor 9 agonist, CpG-oligodeoxynucleotide 1826, ameliorates cardiac dysfunction after trauma-hemorrhage.
Zhang X; Gao M; Ha T; Kalbfleisch JH; Williams DL; Li C; Kao RL
Shock; 2012 Aug; 38(2):146-52. PubMed ID: 22576005
[TBL] [Abstract][Full Text] [Related]
8. Midazolam suppresses ischemia/reperfusion-induced cardiomyocyte apoptosis by inhibiting the JNK/p38 MAPK signaling pathway.
Zhou W; Cai D
Can J Physiol Pharmacol; 2022 Feb; 100(2):117-124. PubMed ID: 34559975
[TBL] [Abstract][Full Text] [Related]
9. CpG-ODN promotes phagocytosis and autophagy through JNK/P38 signal pathway in Staphylococcus aureus-stimulated macrophage.
Wu HM; Wang J; Zhang B; Fang L; Xu K; Liu RY
Life Sci; 2016 Sep; 161():51-9. PubMed ID: 27476088
[TBL] [Abstract][Full Text] [Related]
10. Effect of isoflurane on myocardial ischemia-reperfusion injury through the p38 MAPK signaling pathway.
Zhou Y; Peng DD; Chong H; Zheng SQ; Zhu F; Wang G
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1342-1349. PubMed ID: 30779102
[TBL] [Abstract][Full Text] [Related]
11. CpG-ODN exerts a neuroprotective effect via the TLR9/pAMPK signaling pathway by activation of autophagy in a neonatal HIE rat model.
Ye L; Feng Z; Doycheva D; Malaguit J; Dixon B; Xu N; Zhang JH; Tang J
Exp Neurol; 2018 Mar; 301(Pt A):70-80. PubMed ID: 29274721
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 9 signaling promotes autophagy and apoptosis via divergent functions of the p38/JNK pathway in human salivary gland cells.
Fu J; Shi H; Cao N; Wu S; Zhan T; Xie L; Wang Z; Ye L; Li C; Shen Y; Yu C; Zheng L
Exp Cell Res; 2019 Feb; 375(2):51-59. PubMed ID: 30610847
[TBL] [Abstract][Full Text] [Related]
13. Heat Shock Protein 70 Protects the Heart from Ischemia/Reperfusion Injury through Inhibition of p38 MAPK Signaling.
Song N; Ma J; Meng XW; Liu H; Wang H; Song SY; Chen QC; Liu HY; Zhang J; Peng K; Ji FH
Oxid Med Cell Longev; 2020; 2020():3908641. PubMed ID: 32308802
[TBL] [Abstract][Full Text] [Related]
14. CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis.
Zhou DC; Su YH; Jiang FQ; Xia JB; Wu HY; Chang ZS; Peng WT; Song GH; Park KS; Kim SK; Cai DQ; Zheng L; Qi XF
J Cell Physiol; 2018 May; 233(5):4245-4257. PubMed ID: 29057537
[TBL] [Abstract][Full Text] [Related]
15. CpG DNA modulates interleukin 1beta-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells.
Parilla NW; Hughes VS; Lierl KM; Wong HR; Page K
Respir Res; 2006 Jun; 7(1):84. PubMed ID: 16740161
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression.
Lim EJ; Lee SH; Lee JG; Kim JR; Yun SS; Baek SH; Lee C
Exp Mol Med; 2007 Apr; 39(2):239-45. PubMed ID: 17464186
[TBL] [Abstract][Full Text] [Related]
17. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of total flavones of Choerospondias axillaries on ischemia/reperfusion-induced myocardial infarction-related MAPK signaling pathway.
Li C; He J; Gao Y; Xing Y; Hou J; Tian J
Cardiovasc Toxicol; 2014 Jun; 14(2):145-52. PubMed ID: 24297260
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
20. The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice.
Zhou Y; Pan J; Peng Q; Dong Z; Deng L; Wang Y
CNS Neurol Disord Drug Targets; 2017; 16(5):624-633. PubMed ID: 28176622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
